Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCEED: Rebif via RebiSmart in CIS and RMS
NCT02254304Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon beta-1a in multiple sclerosis (MS), clinically isolated syndrome (CIS), sponsored by Merck KGaA. Started Dec 2014; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT02254304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254304.